# A Safety Study to Assess a DNA Vaccine Administered by Particle Mediated Delivery to the Skin in Healthy Subjects

> **NCT00310271** · PHASE1 · COMPLETED · sponsor: **PowderMed** · enrollment: 42 (—)

## Conditions studied

- HSV-2

## Interventions

- **BIOLOGICAL:** pPJV7630 with pPJV2012 administered by PMED

## Key facts

- **NCT ID:** NCT00310271
- **Lead sponsor:** PowderMed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 42 (—)
- **Last updated:** 2008-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00310271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00310271, "A Safety Study to Assess a DNA Vaccine Administered by Particle Mediated Delivery to the Skin in Healthy Subjects". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00310271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*